WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies, 17-21 Nov 2008, WHO HQ, Geneva


MONDAY, 17 NOV 2008

Facilitation: Dr Hans Hogerzeil, Director EMP

08:30-09:00
Registration (M-505, M-Building, WHO/Headquarters)

Introduction

09:00-09:30
Welcome - Objectives of the Seminar
Dr Hans Hogerzeil, Director EMP

09:30-10:15
Introduction of participants: Gallery of experts
Dr Richard Laing, EMP/MIE and Dr Shanthi Pal, QSM

10:15-10:45 Coffee

10:45-11:00
Seminar overview and administration
Mrs Helene Moller, Mrs Ann Wilberforce

11:00-12:00
EMP role and responsibilities in implementing the WHO Medicines Strategy
Dr Hans Hogerzeil, Director EMP

12:00-12:30
Information resources
Mr Claude Da Re, Mrs Kath Hurst, Ms Liz Finney, Mr Jörg Hetzke, Mr Thiago Miranda

12:30-14:00 Lunch


National Medicines Policies

14:00-15:30
National Medicines Policies and Monitoring Implementation
Dr Richard Laing, EMP/MIE

15:30-15:45 Tea


Selection of Essential Medicines

15:45-17:15
Update 2006 WHO Model List of Essential Medicines Selection, and Paediatric Medicines
Dr Suzanne Hill, EMP/MAR

17:30-19:00 Reception with EMP staff members (WHO Restaurant, Main Building)

TUESDAY, 18 NOV 2008

Facilitation: Dr Sabine Kopp, EMP/QSM







What is quality?


09:00-10:45
Medicines - Quality Control and Assurance
WHO normative functions in the field of pharmaceuticals
Dr Sabine Kopp, EMP/QSM

10:45-11:00 Coffee

11:00-12:30
Drug Regulatory Overview
Dr Milan Smid, EMP/QSM (tbc)

12:30-14:00 Lunch
Optional Lunchtime Seminar, Room M105
"Conflicts of Interest and Guideline Development"
Prof. Lisa Bero, University of California, San Francisco


Prequalification

14:00-15:45
Prequalification of Essential Medicines
Dr Raul Kiivet & Dr André Van Zyl, EMP/QSM

15:45-16:00 Tea


16:00-17:00
Quality Control Assurance for Blood Products and Related Biologicals
Dr Ana Padilla, EMP/QSM

Evening: Dinner in Geneva (optional - all have to pay for themselves, sorry!)

WEDNESDAY, 19 NOV 2008

Facilitation: Dr Richard Laing, EMP/MIE



What is access?

09:00-10:30
Panel presentation and discussion
Access framework, Medicines Supply
Dr Helene Moller & Ms Magali Babaley, EMP/MAR

GLOBAL FUND - Ms Thuy Hung Ha
UNITAID - Dr Jorge Bermudez
GDF/TB - Mr Robert Matiru
UNICEF - Mr Jan Kmorska
WHO/CPS - Mr Ahmed Bellah
HTM/HIV - Mr Boniface Dongmo Nguimfack
GMP/SCM - Ms Sylvia Schwarte
ICRC - Ms Stephanie Arsac-Janvier

10:30-10:45 Coffee

10:45-12:15
Discussion and conclusion

12:30-14:00 Lunch
Optional Lunchtime Seminar, Room M505
"World Health Survey - Access to Medicines - Work in Progress"
Ms Sheila Reis, Harvard Medical School


Medicine Prices & Financing

14:00-15:15
Medicine prices, WHO/NGO Price Survey Methodology
Ms Alexandra Cameron, EMP/MAR, Dr Richard Laing, EMP/MIE

15:15-15:30 Tea

15:30-17:00
Hot topics to be selected from:

THURSDAY, 20 NOV 2008

Facilitation: Dr Gilles Forte, EMP/MPC

Medicines Procurement & Supply Management Issues in the African Region

09:00-09:30
WHO Strategy for working with and in countries
Dr Gilles Forte, EMP/MPC

09:30-10:00
Mapping Partners involved in Medicines supply & distribution and In-depth Assessment of Medicines Supply management systems
Mrs Magali Babaley, EMP/MPC

10:00-10:30
Use of evidence in strengthening medicines supply systems: The case of Tanzania
Mr Joseph Muhume, MOH/Tanzania

10:30-10:45 Coffee

10:45-11:30
Discussion on regional and country activities

11:30-12:30
Human Rights and Access to Essential Medicines
Dr Hendrik V. Hogerzeil, Director EMP

12:30-14:00 Lunch


Facilitation: Dr Helene Moller, EMP/PAR

Global Issues

14:00-15:30
Global Strategy and Plan of Action on Public Health, Innovation and Intellectual Property
Dr Elil Renganathan, DGD/PHI

15:30-15:45 Tea

15:45-16:45
International Regulatory Cooperation for Herbal Medicines (IRCH)
Dr Xiaorui Zhang, EMP/TRM

FRIDAY, 21 NOV 2008

Facilitation: Dr Clive Ondari, EMP/MAR







Safety

09:00-10:15
Pharmacovigilance: New challenges for WHO
Dr Mary Couper & Dr Shanti Pal, EMP/QSM

10:15-10:30 Coffee

10:30-12:30
Promoting rational use of medicines
Dr Kathleen Holloway, EMP/PAR

12:30
Closure
Dr Clive Ondari, EMP/MAR

14:00
Additional time for sessions or individual appointments with EMP staff

[an error occurred while processing this directive]